106 related articles for article (PubMed ID: 20070543)
21. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging.
Yu CM; Zhang Q; Fung JW; Chan HC; Chan YS; Yip GW; Kong SL; Lin H; Zhang Y; Sanderson JE
J Am Coll Cardiol; 2005 Mar; 45(5):677-84. PubMed ID: 15734610
[TBL] [Abstract][Full Text] [Related]
22. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
[TBL] [Abstract][Full Text] [Related]
23. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.
St John Sutton MG; Plappert T; Abraham WT; Smith AL; DeLurgio DB; Leon AR; Loh E; Kocovic DZ; Fisher WG; Ellestad M; Messenger J; Kruger K; Hilpisch KE; Hill MR;
Circulation; 2003 Apr; 107(15):1985-90. PubMed ID: 12668512
[TBL] [Abstract][Full Text] [Related]
24. Relation of left ventricular lead placement in cardiac resynchronization therapy to left ventricular reverse remodeling and to diastolic dyssynchrony.
Rovner A; de Las Fuentes L; Faddis MN; Gleva MJ; Dávila-Román VG; Waggoner AD
Am J Cardiol; 2007 Jan; 99(2):239-41. PubMed ID: 17223425
[TBL] [Abstract][Full Text] [Related]
25. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
[TBL] [Abstract][Full Text] [Related]
26. Impact of interlead distance on immediate and mid-term response to cardiac resynchronization therapy.
Wang J; Su Y; Cui J; Chen H; Qin S; Ge J
Scand Cardiovasc J; 2013 Oct; 47(5):263-70. PubMed ID: 23941703
[TBL] [Abstract][Full Text] [Related]
27. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
[TBL] [Abstract][Full Text] [Related]
28. Right ventricular lead adjustment in cardiac resynchronization therapy and acute hemodynamic response: a pilot study.
Kumar P; Upadhyay GA; Cavaliere-Ogus C; Heist EK; Altman RK; Chatterjee NA; Parks KA; Singh JP
J Interv Card Electrophysiol; 2013 Apr; 36(3):223-31. PubMed ID: 23263893
[TBL] [Abstract][Full Text] [Related]
29. Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices.
Horwich T; Foster E; De Marco T; Tseng Z; Saxon L
J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1284-9. PubMed ID: 15574179
[TBL] [Abstract][Full Text] [Related]
30. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of left ventricular systolic dyssynchrony by real-time three-dimensional echocardiography to predict long-term response to cardiac resynchronization therapy.
Soliman OI; Geleijnse ML; Theuns DA; van Dalen BM; Vletter WB; Jordaens LJ; Metawei AK; Al-Amin AM; ten Cate FJ
Am J Cardiol; 2009 Jun; 103(11):1586-91. PubMed ID: 19463520
[TBL] [Abstract][Full Text] [Related]
32. Value of baseline left lateral wall postsystolic displacement assessed by M-mode to predict reverse remodeling by cardiac resynchronization therapy.
Sassone B; Capecchi A; Boggian G; Gabrieli L; Saccà S; Vandelli R; Petracci E; Mele D
Am J Cardiol; 2007 Aug; 100(3):470-5. PubMed ID: 17659931
[TBL] [Abstract][Full Text] [Related]
33. Relation of response to cardiac resynchronization therapy to left ventricular reverse remodeling.
Vidal B; Sitges M; Marigliano A; Díaz-Infante E; Azqueta M; Tamborero D; Macías A; Roig E; Brugada J; Paré C; Mont L
Am J Cardiol; 2006 Mar; 97(6):876-81. PubMed ID: 16516593
[TBL] [Abstract][Full Text] [Related]
34. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure.
St John Sutton M; Ghio S; Plappert T; Tavazzi L; Scelsi L; Daubert C; Abraham WT; Gold MR; Hassager C; Herre JM; Linde C;
Circulation; 2009 Nov; 120(19):1858-65. PubMed ID: 19858419
[TBL] [Abstract][Full Text] [Related]
35. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.
Porciani MC; Macioce R; Demarchi G; Chiostri M; Musilli N; Cappelli F; Lilli A; Ricciardi G; Padeletti L
Eur J Echocardiogr; 2006 Jan; 7(1):31-9. PubMed ID: 16378918
[TBL] [Abstract][Full Text] [Related]
36. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
[TBL] [Abstract][Full Text] [Related]
37. Improvement of atrial function and atrial reverse remodeling after cardiac resynchronization therapy for heart failure.
Yu CM; Fang F; Zhang Q; Yip GW; Li CM; Chan JY; Wu L; Fung JW
J Am Coll Cardiol; 2007 Aug; 50(8):778-85. PubMed ID: 17707183
[TBL] [Abstract][Full Text] [Related]
38. Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations.
Zhang Q; Chan YS; Liang YJ; Fang F; Lam YY; Chan CP; Lee AP; Chan KC; Wu EB; Yu CM
Int J Cardiol; 2013 Aug; 167(3):889-93. PubMed ID: 22330007
[TBL] [Abstract][Full Text] [Related]
39. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.
Inage T; Yoshida T; Hiraki T; Ohe M; Takeuchi T; Nagamoto Y; Fukuda Y; Gondo T; Imaizumi T
Europace; 2008 Mar; 10(3):379-83. PubMed ID: 18227354
[TBL] [Abstract][Full Text] [Related]
40. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
